{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:42:09Z","timestamp":1791214929575,"version":"4.1.0"},"reference-count":29,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: The therapeutic efficacy of extended lymph node dissection (ePLND) for intermediate- and high-risk (IR\/HR) prostate cancer remains controversial. This study evaluated whether PLND improved biochemical recurrence (BCR) rates in patients with prostate cancer undergoing robotic-assisted radical prostatectomy (RARP) using a propensity matching method with cases from two facilities. Methods: The study included 1002 patients with IR\/HR disease who underwent RARP at two facilities with equivalent surgical techniques and hospital size but different ePLND policies for IR\/HR between July 2012 and November 2022. We compared perioperative outcomes, complications, and biochemical recurrence-free survival (bRFS) between the centers. Results: After propensity matching, 221 and 124 cases, each at intermediate and high risk, respectively, were compared. Except for age, preoperative clinicopathological variables did not differ significantly between the matched ePLND and non-PLND groups. A median of 18 lymph nodes were assessed in the dissection group. The 3-year bRFS rates did not differ significantly between ePLND and non-PLND among intermediate-risk and high-risk patients. The dissection group had significantly longer operative times and more complications associated with ePLND, including lower extremity edema, pelvic hematoma, and neuropathy. A multivariable Cox regression analysis performed after propensity adjustment identified initial prostate-specific antigens, pathological tumor stage (high-risk only), and positive surgical margins as independent prognostic factors for bRFS while ePLND was not significant. Conclusions: These results suggest that ePLND may not be necessary in intermediate- to high-risk PCa patients undergoing RARP, although further study with a longer follow-up is required.<\/jats:p>","DOI":"10.3390\/cancers17040655","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T11:14:41Z","timestamp":1739531681000},"page":"655","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Extended Lymph Node Dissection May Not Provide a Therapeutic Benefit in Patients with Intermediate-to High-Risk Prostate Cancer Treated with Robotic-Assisted Radical Prostatectomy"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2229-0948","authenticated-orcid":false,"given":"Noriyoshi","family":"Miura","sequence":"first","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0407-7123","authenticated-orcid":false,"given":"Masaki","family":"Shimbo","sequence":"additional","affiliation":[{"name":"Department of Urology, St. Luke\u2019s International Hospital, Tokyo 104-8560, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Okawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Sugihara","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatora","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Haga","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruna","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osuke","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6656-4261","authenticated-orcid":false,"given":"Ryuta","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8992-4167","authenticated-orcid":false,"given":"Tadahiko","family":"Kikugawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takato","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Urology, St. Luke\u2019s International Hospital, Tokyo 104-8560, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyasu","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Urology, St. Luke\u2019s International Hospital, Tokyo 104-8560, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Urology, St. Luke\u2019s International Hospital, Tokyo 104-8560, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Saika","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"ref_1","unstructured":"Comford, P., Tilki, D., van den Bergh, R.C.N., Briers, E., Eberli, D., De Meerleer, G., De Santis, M., Gillessen, S., Henry, A.M., and van Leenders, G.J.L.H. (2024, December 26). EAU Guidelines. Available online: https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-EANM-ESTRO-ESUR-ISUP-SIOG-Guidelines-on-Prostate-Cancer-2024_2024-04-09-132035_ypmy_2024-04-16-122605_lqpk.pdf."},{"key":"ref_2","unstructured":"(2024, December 26). NCCN Guidelines: Prostate Cancer version 1.2025. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JU.0000000000002758","article-title":"Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up","volume":"208","author":"Eastham","year":"2022","journal-title":"J. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/JU.0000000000000504","article-title":"Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D\u2019Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study","volume":"203","author":"Preisser","year":"2020","journal-title":"J. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1245\/s10434-017-5822-6","article-title":"Extended versus Standard Pelvic Lymph Node Dissection in Radical Prostatectomy on Oncological and Functional Outcomes: A Systematic Review and Meta-Analysis","volume":"24","author":"Choo","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1464-410X.2010.09805.x","article-title":"Therapeutic Value of Lymph Node Dissection at Radical Prostatectomy: A Population-Based Case-Cohort Study","volume":"108","author":"Withrow","year":"2011","journal-title":"BJU Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","article-title":"Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.eururo.2014.05.011","article-title":"More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-Positive Prostate Cancer","volume":"67","author":"Abdollah","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/pros.23491","article-title":"Extent of Lymph Node Dissection Improves Survival in Prostate Cancer Patients Treated with Radical Prostatectomy Without Lymph Node Invasion","volume":"78","author":"Preisser","year":"2018","journal-title":"Prostate"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.urology.2006.01.055","article-title":"Impact of Extent of Lymphadenectomy on Survival After Radical Prostatectomy for Prostate Cancer","volume":"68","author":"Joslyn","year":"2006","journal-title":"Urology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/pcan.2015.51","article-title":"Determinants of Long-Term Survival of Patients with Locally Advanced Prostate Cancer: The Role of Extensive Pelvic Lymph Node Dissection","volume":"19","author":"Moschini","year":"2016","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.euo.2021.03.006","article-title":"Limited Versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial","volume":"4","author":"Touijer","year":"2021","journal-title":"Eur. Urol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","article-title":"Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial","volume":"79","author":"Lestingi","year":"2021","journal-title":"Eur. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.euo.2021.02.001","article-title":"Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis","volume":"4","author":"Cacciamani","year":"2021","journal-title":"Eur. Urol. Oncol."},{"key":"ref_15","unstructured":"Chen, J., Wang, Z., Zhao, J., Zhu, S., Sun, G., Liu, J., Zhang, H., Zhang, X., Shen, P., and Shi, M. (2019). Pelvic Lymph Node Dissection and Its Extent on Survival Benefit in Prostate Cancer Patients with a Risk of Lymph Node Invasion >5%: A Propensity Score Matching Analysis From SEER Database. Sci. Rep., 9."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000497280","article-title":"Reconsideration on Clinical Benefit of Pelvic Lymph Node Dissection during Radical Prostatectomy for Clinically Localized Prostate Cancer","volume":"103","author":"Fujimoto","year":"2019","journal-title":"Urol. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eururo.2013.03.057","article-title":"Pelvic Lymph Node Dissection During Robot-Assisted Radical Prostatectomy: Efficacy, Limitations, And Complications-A Systematic Review of the Literature","volume":"65","author":"Ploussard","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2007.07.035","article-title":"The Template of the Primary Lymphatic Landing Sites of the Prostate Should Be Revisited: Results of a Multimodality Mapping Study","volume":"53","author":"Mattei","year":"2008","journal-title":"Eur. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of Surgical Complications: A New Proposal with Evaluation in a Cohort Of 6336 Patients and Results of a Survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the Freely Available Easy-To-Use Software \u2019EZR\u2019 For Medical Statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2024.10.006","article-title":"Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection","volume":"87","author":"Touijer","year":"2025","journal-title":"Eur. Urol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.urology.2016.02.046","article-title":"The Role of Pelvic Lymph Node Dissection During Radical Prostatectomy in Patients With Gleason 6 Intermediate-risk Prostate Cancer","volume":"93","author":"Mandel","year":"2016","journal-title":"Urology"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Namiki, S., Kawase, M., Ebara, S., Tatenuma, T., Sasaki, T., Ikehata, Y., Nakayama, A., Toide, M., Yoneda, T., and Sakaguchi, K. (2022). Pelvic Lymphadenectomy May Not Improve Biochemical Recurrence-Free Survival in Patients with Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy in Japan (The MSUG94 Group). Cancers, 14.","DOI":"10.3390\/cancers14235803"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.eururo.2013.05.026","article-title":"The Role of Robot-Assisted Radical Prostatectomy and Pelvic Lymph Node Dissection in the Management of High-Risk Prostate Cancer: A Systematic Review","volume":"65","author":"Yuh","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11934-017-0696-5","article-title":"Therapeutic Value of Standard Versus Extended Pelvic Lymph Node Dissection During Radical Prostatectomy for High-Risk Prostate Cancer","volume":"18","author":"Colicchia","year":"2017","journal-title":"Curr. Urol. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"108741","DOI":"10.1016\/j.ejso.2024.108741","article-title":"Extraperitoneal Single Port vs Transperitoneal Multiport Robot assisted radical prostatectomy in frail patients: A propensity score matched comparative analysis","volume":"50","author":"Lambertini","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1200\/JCO.2005.04.0756","article-title":"Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal For a Standardized Definition","volume":"24","author":"Stephenson","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.21037\/tau.2018.05.10","article-title":"Surrogate Endpoints in Early Prostate Cancer Research","volume":"7","author":"Williams","year":"2018","journal-title":"Transl. Androl. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1200\/JCO.2017.73.9987","article-title":"Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer","volume":"35","author":"Xie","year":"2017","journal-title":"J. Clin. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/4\/655\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:34:51Z","timestamp":1760027691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/4\/655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["cancers17040655"],"URL":"https:\/\/doi.org\/10.3390\/cancers17040655","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}